Purchase Order 75N92023P00254
Award Date
7/28/23
Potential Completion Date
7/27/24
Potential Value
$100K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Ozgene PTY LTD
Ultimate Awardee
Not listed
NAICS Category
112990 - All Other Animal Production
PSC Category
8820 - Live Animals, Not Raised For Food
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Australia
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services, to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The $148,900.00 contract is for the provision of other functions including the creation of genetically modified knockout and...
This federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), is for Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services for biomedical research. The $70,800.00 firm-fixed-price delivery order is for the exercise of Option Year II of a previous contract, HHSN272200900005I, to provide conditional knockout/knock-in...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $996,710 firm fixed price purchase order to Lumicks USA Inc. to generate HBB, HBBS, and HBBE knock-in mice. The solicitation sought a contractor capable of generating transgenic and knock-in mouse models using CRISPR/Cas9 or other genome editing technologies for biomedical research purposes. No set-aside designation or incumbent contractor was specified. Lumicks will...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), an institute within the National Institutes of Health (NIH), to the prime contractor Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The $56,300.00 firm fixed-price delivery order is for services including gene targeting vector design and creation, mouse embryonic stem cell generation, blastocyst injection,...
This federal contract award, with the ID HHSN272201100215P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The $9,138.50 firm-fixed-price purchase order contract, which has no set-aside designation, is for gene targeting vector design and creation, mouse embryonic stem cell...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Ozgene Pty Ltd, an Australian company that provides genetically modified mice and related services to support biomedical research. The $17,298.00 firm fixed-price delivery order is for additional breeding services for genetically modified knock-in and knock-out mice, which are used to study various diseases and disorders such as...
This federal contract award to Ozgene PTY LTD, an Australian company, is for the delivery of genetically modified mice and related services to support biomedical research at various institutes and centers within the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The specific services provided under this $5,970.00 firm fixed price delivery order contract include gene targeting vector design and creation, mouse embryonic stem cell generation, blastocyst...
This is a definitive contract awarded by the National Institutes of Health (NIH) to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, valued at $38,945,214.78, is for the provision of gene targeting vectors, mouse backcrossing, and the creation of gene knockout and gene knock-in mice to support research into various diseases and disorders, such as hemoglobin disorders, red blood cell development,...
This is a delivery order worth $2,244 awarded to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The order was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), and did not utilize a set-aside designation. Ozgene, as the prime contractor, will provide gene targeting vectors, mouse backcrossing,...
This federal contract award, identified as HHSN272200900005I|HHSN27200015, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), to the prime contractor Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The $7,286.00 Firm Fixed Price contract is for the delivery of additional breeding and mouse...